Servant G, Laporte S A, Leduc R, Escher E, Guillemette G
Département de Pharmacologie, Faculté de Médecine, Université de Sherbrooke, Sherbrooke, Québec J1H 5N4, Canada.
J Biol Chem. 1997 Mar 28;272(13):8653-9. doi: 10.1074/jbc.272.13.8653.
To identify binding domains between angiotensin II (AngII) and its type 2 receptor (AT2), two different radiolabeled photoreactive analogs were prepared by replacing either the first or the last amino acid in the peptide with p-benzoyl-L-phenylalanine (Bpa). Digestion of photolabeled receptors with kallikrein revealed that the two photoreactive analogs label the amino-terminal part of the receptor within the first 182 amino acids. Digestion of 125I-[Bpa1]AngII.AT2 receptor complex with endoproteinase Lys-C produced a glycoprotein of 80 kDa. Deglycosylation of this 80-kDa product decreased its apparent molecular mass to 4.6 kDa and further cleavage of this 4.6-kDa product with V8 protease decreased its molecular mass to 3.6 kDa, circumscribing the labeling site of 125I-[Bpa1]AngII within amino acids 3-30 of AT2 receptor. Treatment of 125I-[Bpa8]AngII.AT2 receptor complex with cyanogen bromide produced two major receptor fragments of 3.6 and 2.6 kDa. Cyanogen bromide hydrolysis of a mutant AT2 receptor produced two major fragments of 12.6 kDa and 2.6 kDa defining the labeling site of 125I-[Bpa8]AngII within residues 129-138 of AT2 receptor. Our results indicate that the amino-terminal tail of the AT2 receptor interacts with the amino-terminal end of AngII, whereas the inner half of the third transmembrane domain of AT2 receptor interacts with the carboxyl-terminal end of AngII.
为了确定血管紧张素II(AngII)与其2型受体(AT2)之间的结合结构域,通过用对苯甲酰-L-苯丙氨酸(Bpa)取代肽中的第一个或最后一个氨基酸,制备了两种不同的放射性标记光反应类似物。用激肽释放酶消化光标记的受体表明,这两种光反应类似物在受体的前182个氨基酸内标记了受体的氨基末端部分。用内肽酶Lys-C消化125I-[Bpa1]AngII.AT2受体复合物产生了一个80 kDa的糖蛋白。对该80 kDa产物进行去糖基化处理后,其表观分子量降至4.6 kDa,用V8蛋白酶对该4.6 kDa产物进一步切割后,其分子量降至3.6 kDa,从而确定了125I-[Bpa1]AngII在AT2受体第3至30个氨基酸内的标记位点。用溴化氰处理125I-[Bpa8]AngII.AT2受体复合物产生了两个主要的受体片段,分子量分别为3.6 kDa和2.6 kDa。溴化氰水解突变型AT2受体产生了两个主要片段,分子量分别为12.6 kDa和2.6 kDa,确定了125I-[Bpa8]AngII在AT2受体第129至138位残基内的标记位点。我们的结果表明,AT2受体的氨基末端尾巴与AngII的氨基末端相互作用,而AT2受体第三个跨膜结构域的内侧一半与AngII的羧基末端相互作用。